Upstream Bio, Inc.
UPB
$9.71
$0.9310.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -21.24M | -15.99M | -12.79M | -12.79M | -11.83M |
| Total Depreciation and Amortization | 49.00K | 14.00K | 13.00K | 13.00K | 14.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.90M | 1.30M | -1.26M | -1.26M | -263.00K |
| Change in Net Operating Assets | -1.32M | 717.00K | 1.24M | 1.24M | -4.03M |
| Cash from Operations | -19.61M | -13.96M | -12.80M | -12.80M | -16.11M |
| Capital Expenditure | -185.00K | -326.00K | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 42.09M | 1.74M | -51.40M | -51.40M | -5.24M |
| Cash from Investing | 41.91M | 1.41M | -51.40M | -51.40M | -5.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 272.75M | 19.00K | 56.00K | 56.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 75.00K | 0.00 | 74.96M | 74.96M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -133.00K |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.18M | -1.66M | -66.50K | -66.50K | -- |
| Cash from Financing | 270.65M | -1.64M | 74.95M | 74.95M | -133.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 292.94M | -14.19M | 10.75M | 10.75M | -21.49M |